BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
25-11-2017

Toimeaine:

betahistine dihydrochloride, Quantity: 8 mg

Saadav alates:

Medis Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

betahistine dihydrochloride

Ravimvorm:

Tablet

Koostis:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Manustamisviis:

Oral

Ühikuid pakis:

100 tablets, 10 tablets, 25 tablets

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Toote kokkuvõte:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2015-11-10